Bloomberg Intelligence cover image

Merger Monday for Banks and Biotech

Bloomberg Intelligence

00:00

How Avidity fits Novartis's post-patent strategy

Sam explains Avidity's late-stage rare-disease assets and how they plug expected revenue gaps post patent expiry.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app